Day: November 12, 2008
The Debate About Off-Label Prescriptions
So-called off-label uses of prescription drugs is an enduring controversy – probably because it involves a trade-off of competing value judgments.The FDA is considering loosening its monitoring of off-label prescriptions, but critics are charging that, if anything, regulations should be tightened. Many issues of science-based medicine are at the core of this controversy. In the US the FDA (Food and Drug Administration)...